Biomarin Pharmaceutical Inc’s recent filing unveils that its EVP, Chief Technical Officer Guyer Charles Greg unloaded Company’s shares for reported $0.5 million on Mar 06 ’25. In the deal valued at $71.28 per share,7,034 shares were sold. As a result of this transaction, Guyer Charles Greg now holds 87,655 shares worth roughly $6.18 million.
Then, Guyer Charles Greg bought 7,034 shares, generating $501,359 in total proceeds.
Before that, Burkhart Erin sold 1,344 shares. Biomarin Pharmaceutical Inc shares valued at $91,903 were divested by the GVP, Chief Accounting Officer at a price of $68.38 per share. As a result of the transaction, Burkhart Erin now holds 13,105 shares, worth roughly $0.92 million.
Oppenheimer upgraded its Biomarin Pharmaceutical Inc [BMRN] rating to an Outperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. William Blair also remained covering BMRN and has decreased its forecast on October 30, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating.
Price Performance Review of BMRN
On Tuesday, Biomarin Pharmaceutical Inc [NASDAQ:BMRN] saw its stock fall -2.14% to $70.49. Over the last five days, the stock has lost -0.03%. Biomarin Pharmaceutical Inc shares have risen nearly 7.24% since the year began. Nevertheless, the stocks have fallen -17.93% over the past one year. While a 52-week high of $94.85 was reached on 03/07/25, a 52-week low of $60.63 was recorded on 01/16/25. SMA at 50 days reached $66.08, while 200 days put it at $73.88.
Levels Of Support And Resistance For BMRN Stock
The 24-hour chart illustrates a support level at 69.58, which if violated will result in even more drops to 68.66. On the upside, there is a resistance level at 71.88. A further resistance level may holdings at 73.26. The Relative Strength Index (RSI) on the 14-day chart is 59.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.23, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 47.19%. Stochastics %K at 74.20% indicates the stock is a holding.
